Amy K. Searle
75 Commercial Road
Melbourne, VIC 3004, Australia
Melbourne, VIC 3004, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Pharmacological Inhibition of Factor XIIa Attenuates Abdominal Aortic Aneurysm, Reduces Atherosclerosis, and Stabilizes Atherosclerotic Plaques.
Journal: Thrombosis and haemostasis
Published: October 07, 2021
A Recombinant Fusion Construct between Human Serum Albumin and NTPDase CD39 Allows Anti-Inflammatory and Anti-Thrombotic Coating of Medical Devices.
Journal: Pharmaceutics
Published: August 23, 2021
Combined Antiplatelet/Anticoagulant Drug for Cardiac Ischemia/Reperfusion Injury.
Journal: Circulation research
Published: August 19, 2020
Myeloperoxidase is a potential molecular imaging and therapeutic target for the identification and stabilization of high-risk atherosclerotic plaque.
Journal: European heart journal
Published: March 09, 2018
Platelet-targeted dual pathway antithrombotic inhibits thrombosis with preserved hemostasis.
Journal: JCI insight
Published: December 18, 2017
Dual-Targeted Theranostic Delivery of miRs Arrests Abdominal Aortic Aneurysm Development.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: November 20, 2017
A single-chain antibody-CD39 fusion protein targeting activated platelets protects from cardiac ischaemia/reperfusion injury.
Journal: European heart journal
Published: November 03, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026